- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 11 residues within 4Å:- Chain A: S.38, M.40, R.300, V.381, W.382
- Chain B: W.380, F.395, H.396, Q.397, E.398
- Ligands: HEM.1
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.300, A:R.300, A:V.381, A:W.382
- pi-Stacking: A:W.382, A:W.382
- pi-Cation interactions: A:W.382
- Hydrophobic interactions: B:E.398
H4B.7: 11 residues within 4Å:- Chain A: W.380, F.395, H.396, Q.397, E.398
- Chain B: S.38, M.40, R.300, V.381, W.382
- Ligands: HEM.6
8 PLIP interactions:1 interactions with chain A, 7 interactions with chain B- Hydrophobic interactions: A:E.398
- Hydrogen bonds: B:R.300, B:R.300, B:V.381, B:W.382
- pi-Stacking: B:W.382, B:W.382
- pi-Cation interactions: B:W.382
- 2 x M5L: 6-[3-(4,4-difluoropiperidin-1-yl)propyl]-4-methylpyridin-2-amine(Non-covalent)
M5L.3: 10 residues within 4Å:- Chain A: P.269, V.271, N.273, F.288, G.290, W.291, Y.292, E.296, Y.410
- Ligands: HEM.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:P.269, A:F.288
- Hydrogen bonds: A:M.293, A:E.296
M5L.8: 10 residues within 4Å:- Chain B: P.269, V.271, N.273, F.288, G.290, W.291, Y.292, E.296, Y.410
- Ligands: HEM.6
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:P.269, B:F.288
- Hydrogen bonds: B:M.293, B:E.296
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 6 residues within 4Å:- Chain A: G.121, I.123, Q.124, W.291, V.353, A.358
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.123, A:Q.124
ACT.9: 6 residues within 4Å:- Chain B: G.121, I.123, Q.124, W.291, V.353, A.358
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:I.123, B:Q.124
- 2 x ZN: ZINC ION(Non-covalent)
ZN.5: 7 residues within 4Å:- Chain A: C.30, C.35, M.36, G.37
- Chain B: C.30, C.35
- Ligands: ZN.10
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Metal complexes: B:C.30, B:C.35, A:C.30, A:C.35
ZN.10: 7 residues within 4Å:- Chain A: C.30, C.35
- Chain B: C.30, C.35, M.36, G.37
- Ligands: ZN.5
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Metal complexes: B:C.30, B:C.35, A:C.30, A:C.35
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vasu, D. et al., 2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors. Bioorg.Med.Chem. (2022)
- Release Date
- 2022-07-13
- Peptides
- Nitric oxide synthase, brain: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
- 2 x M5L: 6-[3-(4,4-difluoropiperidin-1-yl)propyl]-4-methylpyridin-2-amine(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 2 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vasu, D. et al., 2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors. Bioorg.Med.Chem. (2022)
- Release Date
- 2022-07-13
- Peptides
- Nitric oxide synthase, brain: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A